Depression Clinical Trials in Riverside, CA
As of June 2026, 3 paid clinical trials are recruiting for Depression in Riverside, California. Depression studies test rapid-acting antidepressants including ketamine derivatives, psilocybin-assisted therapy, and neuromodulation approaches. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Riverside
Filter results
3 clinical trials for Depression
·Clear filters·↓ Download CSVA Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Study to Assess the Safety and Effectiveness of NMRA-335140-501
About research studies in Riverside
Riverside has approximately 89 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in Riverside
Researchers run research studies in Riverside, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Kaiser Permanente-Riverside | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | 22 |
| Artemis Institute for Clinical Research | Alcohol Use Disorder, Alzheimer Disease, Chronic Low-back Pain | 6 |
| Kaiser Permanente Riverside Medical Center | Age-Related Macular Degeneration, Colorectal Neoplasms, Intracerebral Hemorrhage | 5 |
| Clinical Innovations, Inc. dba CITrials | Bipolar Disorder, Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features | 3 |
| Apex Research | Arteriovenous Fistula, Chronic Kidney Disease, Dialysis; Complications | 2 |
| Kaiser Permanente Riverside Medical Center ( Site 0099) | Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer Metastatic, Prostatic Neoplasms | 2 |
| Neurocrine Clinical Site | Schizophrenia | 2 |
| Riverside Clinical | Alzheimers Disease | 2 |
| University of California, Riverside | Cognitive Change, Hearing Handicap | 2 |
| Artemis Institute for Clinical Research - Riverside | Diabetic Peripheral Neuropathic Pain | 1 |
| CARI Clinical Trials | Venous Thromboembolism (VTE) | 1 |
| CARI Clinical Trials INC /ID# 278844 | Ventral Hernia | 1 |
| CITrials, Inc. - Riverside & San Bernardino County | Schizophrenia | 1 |
| CenExel | Bipolar I Disorder | 1 |
| CenExel CIT | Diabetes, Type 2, Obesity, Overweight | 1 |
| CenExel CIT IE | Schizophrenia Disorders | 1 |
| Clinical Innovations Inc | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 1 |
| Clinical Innovations Inc. DBA CITrials (Riverside) | Schizophrenia | 1 |
| Clinical Innovations, Inc dba CITrials | Obesity and Overweight | 1 |
| Clinical Innovations, Inc. | Schizophrenia | 1 |
| Compassionate Cancer Care Medical Group | Metastatic Non Small Cell Lung Cancer | 1 |
| Glenwood Surge Ctr | Lumbar Spinal Stenosis | 1 |
| Kaiser Permanente - Riverside | Muscle-invasive Urothelial Carcinoma | 1 |
| Kaiser Permanente - Riverside Medical Center /ID# 262413 | AMD, CNV, Wet Age-related Macular Degeneration | 1 |
| Kaiser Permanente - Riverside Medical Center /ID# 263253 | Neovascular Age-related Macular Degeneration | 1 |
Active & Upcoming Studies in Riverside (2026)
Recruiting trials in Riverside grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (29 active studies)
Mental health & behavior (15 active studies)
- Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia · Phase 3 · LB Pharmaceuticals Inc.
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
Neurology & pain (7 active studies)
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain · Phase 2 · Eli Lilly and Company
Diabetes & metabolic (6 active studies)
- A1Cantus vs. Placebo · Phase 2 · University of California, Riverside
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · Pfizer
Eye & vision (3 active studies)
- Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) · Phase 3 · AbbVie
- Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD · Phase 3 · AbbVie
HIV / STI (1 active study)
- California MEPS Hub · University of California, Los Angeles
Cardiovascular (1 active study)
Pediatric (1 active study)
- Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy · Loma Linda University
Common conditions studied in Riverside
- Schizophrenia (6 active studies). Schizophrenia research tests muscarinic agonists, long-acting injectable antipsychotics, and cognitive remediation therapies.
- Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Psoriatic Arthritis (3 active studies). Recruiting Psoriatic Arthritis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Recurrent Lung Non-Small Cell Carcinoma (3 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
- Stage IV Lung Cancer AJCC v8 (3 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Alcohol Use Disorder (2 active studies). Alcohol use disorder trials evaluate GLP-1 agonists, novel pharmacotherapies, and digital therapeutics as adjuncts to behavioral treatment.
Leading research sponsors in Riverside
- NRG Oncology
- Eli Lilly and Company
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- Pfizer
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Riverside. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Riverside
Hipa.ai aggregates every recruiting study in Riverside from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Riverside?
There are approximately 89 recruiting clinical trials in Riverside, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Riverside pay participants?
Most recruiting trials in Riverside compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Riverside?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Riverside?
The most common conditions under active study in Riverside include Schizophrenia (6), Breast Cancer (3), Psoriatic Arthritis (3), Recurrent Lung Non-Small Cell Carcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Riverside?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Riverside on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Riverside?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Riverside?
Recruiting research sites in Riverside include Kaiser Permanente-Riverside, Artemis Institute for Clinical Research, Kaiser Permanente Riverside Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Riverside right now?
The largest active categories in Riverside are Cancer & tumors (29), Mental health & behavior (15), Neurology & pain (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.